Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to treat osteoporosis in postmenopausal women at high risk for fracture, to treat glucocorticoid-induced osteoporosis, and More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.